// App-Quantinova.ai

BSH2020‐PO‐181 : Dynamic and time‐to‐event analyses demonstrate marked reduction in transfusion requirements for janus kinase inhibitor–naïve myelofibrosis patients treated with momelotinib compared head to head with ruxolitinib

Researchers

Presenter

  • D. McLornan

Principal Investigators

  • R. Mesa

  • J. Catalano

  • F. Cervantes

  • T. Devos

  • M. Egyed

  • J. Gotlib

  • J.-J. Kiladjian

  • K. Shimoda

  • E. Coart

  • K. D'hollander

  • R. Donahue

  • M. Kowalski

Medical Centers

  • Department of Haemtology, Guy's Hospital, London, UK

  • UT Health MD Anderson Cancer Center, San Antonio , USA

  • Monash University & Frankston Hospital, Frankston, Australia

  • Department of Pathology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain., Barcelona, Spain

  • Department of Haematology, University Hospitals Leuven and Laboratory of Experimental Transplantation, Leuven, Belgium

  • Department of Haematology, Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary

  • Divisions of Hematology and Oncology and Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA

  • Centre d'Investigations Cliniques

  • Hopital Saint-Louis, AP-HP, Universite Paris , Paris, France

  • University of Miyazaki, Miyazaki, Japan

  • IDDI, Louvain la Neuve, Belgium

  • Sierra Oncology Inc., Vancouver, BC, Canada

Locations

  • United Kingdom

  • United States

  • Australia

  • Spain

  • Belgium

  • Hungary

  • France

  • Japan

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Systemic inflammation

  • Myelofibrosis

  • Anemia

Biomarkers

  • Janus kinase

  • Red Blood Cells

Drug/Treatment

  • Momelotinib

  • Ruxolitinib phosphate

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Active Comparator

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved